Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.

Yu MY, Bartosch B, Zhang P, Guo ZP, Renzi PM, Shen LM, Granier C, Feinstone SM, Cosset FL, Purcell RH.

Proc Natl Acad Sci U S A. 2004 May 18;101(20):7705-10. Epub 2004 May 10.

2.

Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial.

Piazza M, Sagliocca L, Tosone G, Guadagnino V, Stazi MA, Orlando R, Borgia G, Rosa D, Abrignani S, Palumbo F, Manzin A, Clementi M.

Arch Intern Med. 1997 Jul 28;157(14):1537-44.

PMID:
9236555
3.

Detection and characterization of hepatitis C virus RNA in immune globulins.

Yu MY, Mason BL, Tankersley DL.

Transfusion. 1994 Jul;34(7):596-602.

PMID:
7519795
4.

In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes.

Bartosch B, Bukh J, Meunier JC, Granier C, Engle RE, Blackwelder WC, Emerson SU, Cosset FL, Purcell RH.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14199-204. Epub 2003 Nov 14.

5.

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.

Zhang P, Zhong L, Struble EB, Watanabe H, Kachko A, Mihalik K, Virata-Theimer ML, Alter HJ, Feinstone S, Major M.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7537-41. doi: 10.1073/pnas.0902749106. Epub 2009 Apr 20.

6.

The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C.

Biswas RM, Nedjar S, Wilson LT, Mitchell FD, Snoy PJ, Finlayson JS, Tankersley DL.

Transfusion. 1994 Feb;34(2):100-4.

PMID:
7508642
7.

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.

Fournier C, Duverlie G, François C, Schnuriger A, Dedeurwaerder S, Brochot E, Capron D, Wychowski C, Thibault V, Castelain S.

Virol J. 2007 Mar 30;4:35.

8.

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.

Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, Weiner AJ, Lau JY, Choo QL, Chien D, Pileri P, Houghton M, Abrignani S.

Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1759-63.

9.

Effect of immune globulin on the prevention of experimental hepatitis C virus infection.

Krawczynski K, Alter MJ, Tankersley DL, Beach M, Robertson BH, Lambert S, Kuo G, Spelbring JE, Meeks E, Sinha S, Carson DA.

J Infect Dis. 1996 Apr;173(4):822-8.

PMID:
8603959
10.

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.

Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15394-9.

11.

Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.

Cao J, Chen Z, Ren Y, Luo Y, Cao M, Lu W, Zhao P, Qi Z.

Vaccine. 2011 May 9;29(20):3714-23. doi: 10.1016/j.vaccine.2011.02.083. Epub 2011 Mar 9.

PMID:
21396407
12.
13.

Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.

Barth H, Rybczynska J, Patient R, Choi Y, Sapp RK, Baumert TF, Krawczynski K, Liang TJ.

Hepatology. 2011 Oct;54(4):1135-48. doi: 10.1002/hep.24489. Epub 2011 Aug 11.

14.

Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees.

Wang YF, Brotman B, Andrus L, Prince AM.

J Infect Dis. 1996 Apr;173(4):808-21.

PMID:
8603958
15.

Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma.

Zhang P, Wu CG, Mihalik K, Virata-Theimer ML, Yu MY, Alter HJ, Feinstone SM.

Proc Natl Acad Sci U S A. 2007 May 15;104(20):8449-54. Epub 2007 May 9.

16.

How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus?

Rabenau H, Schütz R, Berger A, Doerr HW, Weber B.

Infusionsther Transfusionsmed. 1996 Jun;23(3):124-30.

PMID:
8782708
17.

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

Forns X, Payette PJ, Ma X, Satterfield W, Eder G, Mushahwar IK, Govindarajan S, Davis HL, Emerson SU, Purcell RH, Bukh J.

Hepatology. 2000 Sep;32(3):618-25.

PMID:
10960458
18.

The hepatitis C virus glycan shield and evasion of the humoral immune response.

Helle F, Duverlie G, Dubuisson J.

Viruses. 2011 Oct;3(10):1909-32. doi: 10.3390/v3101909. Epub 2011 Oct 14. Review.

19.

Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees.

Shata MT, Anthony DD, Carlson NL, Andrus L, Brotman B, Tricoche N, McCormack P, Prince A.

J Viral Hepat. 2002 Nov;9(6):400-10.

PMID:
12431201
20.

Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.

Major ME, Mihalik K, Puig M, Rehermann B, Nascimbeni M, Rice CM, Feinstone SM.

J Virol. 2002 Jul;76(13):6586-95.

Supplemental Content

Support Center